Changes

Jump to navigation Jump to search
no edit summary
|Series=Government Policy
|Content status=Revision
|Notes=Sent Julia to respond to Anne on 11/21's comments and consult Iris re: FDA approval process.
}}
 
==Abstract==
This post looks at the USPTO's recently established "Patents 4 Patients" Program, which aims to accelerate research by quickening the patent examination process. However, subject matter eligibility criteria also seems to be playing a part in hindering research.

Navigation menu